Multiple inflammatory and apoptotic pathway proteins

Multiple inflammatory and apoptotic pathway proteins refers to a broad and heterogeneous group of molecular mediators that regulate the body's response to pathological stimuli and the execution of programmed cell death. This category encompasses diverse protein families, including pro-inflammatory cytokines like Tumor Necrosis Factor (TNF), transcription factors such as Nuclear Factor-kappa B (NF-κB), and the caspase family of cysteine proteases (Source: Nature Reviews Molecular Cell Biology, 2017). These pathways are highly integrated; for instance, signaling through the TNF receptor can lead to either cell survival via inflammatory gene expression or cell death via the apoptotic cascade, depending on the cellular environment and the presence of specific adapter proteins (Source: Science, 2014). Dysregulation of these proteins is a fundamental driver of chronic inflammatory conditions, autoimmune diseases, and the evasion of cell death in cancer (Source: NIH, National Institute of General Medical Sciences). While numerous therapeutic agents—such as monoclonal antibodies (e.g., Infliximab) and small molecule inhibitors (e.g., Venetoclax)—successfully target specific nodes within these networks, the term itself describes a functional grouping rather than a single, discrete therapeutic target (Source: PubMed, PMID: 30232416). Consequently, pharmacological strategies must be precisely tailored to specific proteins within these pathways to achieve efficacy while minimizing the risks of systemic immunosuppression or off-target toxicity.

Other names

Inflammatory and apoptotic signaling moleculesPro-inflammatory and pro-apoptotic factorsMediators of inflammation and cell deathInflammatory pathway proteinsApoptotic pathway proteins

Modulation of signaling cascades including the NF-κB, MAPK, and JAK/STAT pathways, or direct inhibition of apoptotic regulators like BCL-2 and caspases (Source: StatPearls, 2023).